KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Operating Leases (2021 - 2025)

Hims & Hers Health's Operating Leases history spans 5 years, with the latest figure at $148.0 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 1465.25% year-over-year to $148.0 million; the TTM value through Dec 2025 reached $148.0 million, up 1465.25%, while the annual FY2025 figure was $148.0 million, 1465.25% up from the prior year.
  • Operating Leases for Q4 2025 was $148.0 million at Hims & Hers Health, up from $143.6 million in the prior quarter.
  • Across five years, Operating Leases topped out at $148.0 million in Q4 2025 and bottomed at $3.2 million in Q1 2023.
  • The 5-year median for Operating Leases is $8.7 million (2023), against an average of $29.7 million.
  • The largest annual shift saw Operating Leases fell 17.25% in 2023 before it soared 1465.25% in 2025.
  • A 5-year view of Operating Leases shows it stood at $4.1 million in 2021, then decreased by 11.37% to $3.6 million in 2022, then surged by 137.52% to $8.7 million in 2023, then grew by 9.1% to $9.5 million in 2024, then skyrocketed by 1465.25% to $148.0 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Operating Leases are $148.0 million (Q4 2025), $143.6 million (Q3 2025), and $74.9 million (Q2 2025).